Background: The emergence of antibiotic resistance and the continuing evolution of
resistance even to newer drugs have always been a global challenge. In the pursuit of …

Aims: Globally, scientists are working to find more efficient antimicrobial drugs to treat
microbial infections and kill drug-resistant bacteria. Background: Despite the availability of …

For many years, combination therapies with two or more antimicrobial agents have gained
interest to address the problem of emerging antibiotic resistance. Several studies have …

The emergence of antibiotic-and/or multidrug-resistant bacteria is recognized as a crucial
challenge for public health. The potential of AgNps as an anti-microbial agent is greatly …

The emergence of multidrug resistance in bacterial infections has limited the use of
antibiotics. Helping the action of antibiotics is one of the needs of the day. Today, the …

Nanoparticles have gained considerable attention in recent era among which, silver
nanoparticles (AgNPs) have demonstrated exceptional characteristics in medical sciences …

Background Multidrug-resistant (MDR) bacteria are acknowledged as one of the main
factors contributing to chronic illnesses and fatalities globally. Numerous diseases, including …

For many years, combination therapies with two or more antimicrobial agents have gained
interest to address the problem of emerging antibiotic resistance. Several studies have …

Resistance to antimicrobial agents by pathogenic bacteria has emerged in recent years and
is a major challenge for the health care industry. For developing a cheap broad‐active agent …

Background: The quandary of antimicrobial resistance is rapidly becoming a cause for
global concern. Meanwhile, green biological synthesis of silver nanoparticles is being …